EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor Microenvironment in Triple-Negative Breast Cancer and Targeting Approaches

Youli Li, Yang Chen, Yuxin Mu, Xuemei Xiu, Wenxing Qin

Cancer Biome and Targeted Therapy · 24.01.2026 · 1-31

DOI: 10.66505/cbtt.v1i1.5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biome and Targeted Therapy, online erschienen am 24.01.2026. Verfasst von Youli Li und 4 weiteren Autor:innen. Die Arbeit nennt 182 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous subtype of breast cancer with high recurrence and early metastasis. Unlike hormone receptor-positive or HER2-positive cancers, TNBC lacks targeted therapies, and standard chemotherapy often yields limited and transient responses, making treatment challenging. The tumor microenvironment (TME) plays a central role in TNBC progression, immune evasion, and therapy resistance. It comprises multiple cellular components, tumor-associated macrophages (TAMs), cancer-associated fibroblasts (CAFs), tumor-infiltrating lymphocytes (TILs), and myeloid-derived suppressor cells (MDSCs), as well as structural and signaling elements such as the extracellular matrix (ECM), growth factors, and cytokines. Interactions among these components create an immunosuppressive, pro-tumorigenic milieu that supports cancer cell survival, invasion, and metastasis. Targeting the TME has emerged as a promising therapeutic strategy. Immunotherapies, particularly immune checkpoint inhibitors (ICIs), can restore antitumor immunity by reversing T cell exhaustion and mitigating immune suppression. Response rates remain variable, leading to the exploration of combination approaches that pair ICIs with chemotherapy, radiotherapy, or TME-modulating agents to enhance efficacy. Direct targeting of TME components, including CAFs, TAMs, MDSCs, and ECM remodeling enzymes, is also being developed to disrupt the supportive tumor niche and enhance drug delivery. This review provides a comprehensive overview of the TNBC TME, emphasizing its role in tumor progression and therapy resistance, and summarizes current and emerging strategies to target the TME. By clarifying complex cellular and molecular interactions, these approaches aim to sensitize tumors to therapy, prevent metastasis, and support the development of more effective, personalized treatments for TNBC.

Zitieren

APA

Li, Y., Chen, Y., Mu, Y., Xiu, X., & Qin, W. (2026). Tumor Microenvironment in Triple-Negative Breast Cancer and Targeting Approaches. Cancer Biome and Targeted Therapy, 1-31. https://doi.org/10.66505/cbtt.v1i1.5

Vancouver

Li Y, Chen Y, Mu Y, Xiu X, Qin W. Tumor Microenvironment in Triple-Negative Breast Cancer and Targeting Approaches. Cancer Biome and Targeted Therapy. 2026:1-31. doi:10.66505/cbtt.v1i1.5

BibTeX
@article{Li2026,
  author = {Li, Youli and Chen, Yang and Mu, Yuxin and Xiu, Xuemei and Qin, Wenxing},
  title = {Tumor Microenvironment in Triple-Negative Breast Cancer and Targeting Approaches},
  journal = {Cancer Biome and Targeted Therapy},
  year = {2026},
  pages = {1--31},
  doi = {10.66505/cbtt.v1i1.5}
}
Kostenlos starten →